Evidence map›Paper›PMID 37905771›Full record

ArticleGenes, chromosomes & cancer2024

A case of spindle cell rhabdomyosarcoma with a ZFP64::NCOA3 fusion.

Ken-Ichi Yoshida, Yoji Kukita, Harumi Nakamura, Toru Wakamatsu, Keiichiro Honma, Toshinari Yagi

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Genes, chromosomes & cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Clinicopathologic and Molecular Genetic Features of Spindle Cell Rhabdomyosarcoma Harboring ZFP64::NCOA2/3 Fusions: A Series of 14 Cases.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ken-Ichi YoshidaDepartment of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.ORCID 0000-0002-1549-1514
Yoji KukitaLaboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan.
Harumi NakamuraLaboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan.
Toru WakamatsuDepartment of Orthopedic Surgery, Osaka International Cancer Institute, Osaka, Japan.
Keiichiro HonmaDepartment of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
Toshinari YagiDepartment of Outpatient Chemotherapy, Osaka International Cancer Institute, Osaka, Japan.
Osaka International Cancer Institute · JPOsaka International Cancer Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RhabdomyosarcomaRhabdomyosarcoma, EmbryonalAdultChildDNA-Binding ProteinsHumansNuclear Receptor Coactivator 3Transcription FactorsDNA-Binding ProteinsNCOA3 protein, humanNuclear Receptor Coactivator 3Transcription FactorsZFP64 protein, human

Identifiers

PMID37905771
OpenAlexW4388034510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.